QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 284 filers reported holding QIAGEN NV in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,926 | -9.9% | 117 | 0.0% | 0.00% | – |
| Q2 2022 | $5,467 | -52.0% | 117 | -49.1% | 0.00% | – |
| Q1 2022 | $11,394 | -86.7% | 230 | -85.1% | 0.00% | -100.0% |
| Q4 2021 | $85,512 | +10.6% | 1,540 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $77,283 | +7.4% | 1,489 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $71,968 | -6.6% | 1,489 | -6.3% | 0.00% | 0.0% |
| Q1 2021 | $77,067 | -16.1% | 1,589 | -8.6% | 0.00% | -40.0% |
| Q4 2020 | $91,906 | +1844.3% | 1,739 | +1811.0% | 0.01% | – |
| Q3 2020 | $4,727 | +20.6% | 91 | 0.0% | 0.00% | – |
| Q2 2020 | $3,918 | -59.5% | 91 | -62.2% | 0.00% | -100.0% |
| Q1 2020 | $9,680 | +12.8% | 241 | -5.1% | 0.00% | 0.0% |
| Q4 2019 | $8,585 | +79.6% | 254 | +74.0% | 0.00% | – |
| Q3 2019 | $4,781 | +113.9% | 146 | +165.5% | 0.00% | – |
| Q2 2019 | $2,235 | +358.9% | 55 | +358.3% | 0.00% | – |
| Q1 2019 | $487 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |